$8.65 billion EBITDA for full year 2024,sees a rise of 14% year-on-year (YoY) Full year 2024 dividend of $3.41 billion confirmed,growing by 5% per annum
SUZHOU,China,Feb. 6,2025-- Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co.,Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody
SHENZHEN,China,Feb. 6,2025-- Elegoo,a rapidly developing brand in global smart manufacturing,announces today on its website that pre-ordersfor the highly anticipated Centauri Carbon,the company\'sfir
Personetics\' latest product release empowers financial institutions to develop highly personalized customer experiences that democratize financial advice,inspire action,and drive business value
Cobots,via low ASPs and safety coupled with AI value-adds,will unlock new commercial applications for robotics
SHANGHAI,Feb. 6,2025--ShanghaiHenlius Biotech,Inc. (2696.HK) today announced it has entered into a license agreement with Dr. Reddy\'s Laboratories SA,wholly-owned subsidiary of Dr. Reddy\'s Laborator